Das Produkt wurde korrekt in den Warenkorb gelegt.

discount label
H-SLSLSPGK-OH
3D-Ansicht

Biosynth logo

H-SLSLSPGK-OH

Ref. 3D-PP47581

1mg
202,00 €
10mg
234,00 €
100mg
412,00 €
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 27. Dezember 2024

Produktinformation

Name:
H-SLSLSPGK-OH
Beschreibung:

Peptide H-SLSLSPGK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SLSLSPGK-OH include the following: Structural elucidation of post-translational modifications in monoclonal antibodies W Li, JL Kerwin, J Schiel, T Formolo - State-of-the-art and , 2015 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bk-2015-1201.ch003 Characterization of C-terminal and Disulfide Bond Peptides of Monoclonal Antibody (mAb) on Q-TOF Mass Spectrometer U Jumhawan, Z Zhan - shopshimadzu.comhttps://www.shopshimadzu.com/frontend/web/upload/2022/02/10/AD-01901644455294.pdf Native mass spectrometry combined with enzymatic dissection unravels glycoform heterogeneity of biopharmaceuticals T Wohlschlager , K Scheffler, IC Forstenlehner - Nature , 2018 - nature.comhttps://www.nature.com/articles/s41467-018-04061-7 Attribute analytics performance metrics from the MAM consortium interlaboratory study T Mouchahoir, JE Schiel, R Rogers - Journal of the , 2022 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jasms.2c00129 chromatography mass spectrometry with a heavy peptide response curve accurately measures unprocessed C-terminal lysine during peptide mapping analysis of T Greer , ROB Johnson, M Cejkov, X Zheng - Journal of Pharmaceutical , 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0731708521000753 LC-MS based case-by-case analysis of the impact of acidic and basic charge variants of bevacizumab on stability and biological activity SK Singh , D Kumar , H Malani , AS Rathore - Scientific reports, 2021 - nature.comhttps://www.nature.com/articles/s41598-020-79541-2 Characterization of a complex glycoprotein whose variable metabolic clearance in humans is dependent on terminal N-acetylglucosamine content R Keck, N Nayak, L Lerner, S Raju, S Ma - Biologicals, 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1045105607000735 C-terminal modification of monoclonal antibody drugs: amidated species as a general product-related substance M Tsubaki, I Terashima, K Kamata, A Koga - International journal of , 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0141813012003704 C-terminal lysine variants in fully human monoclonal antibodies: Investigation of test methods and possible causes LW Dick Jr , D Qiu, D Mahon, M Adamo - Biotechnology and , 2008 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/bit.21855 Monoclonal antibody charge variant characterization by fully automated four-dimensional liquid chromatography-mass spectrometry L Verscheure, A Cerdobbel, P Sandra , F Lynen - of Chromatography A, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0021967321005331 The versatility of heart-cutting and comprehensive two-dimensional liquid chromatography in monoclonal antibody clone selection K Sandra , M Steenbeke, I Vandenheede - of Chromatography A, 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0021967317309202 Peptide Mapping of Monoclonal Antibodies and Antibody--Drug Conjugates Using Micro-Pillar Array Columns Combined with Mass Spectrometry. K Sandra , J Vandenbussche, I Vandenheede - LC-GC , 2018 - search.ebscohost.comhttps://search.ebscohost.com/login.aspx?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=14716577&AN=128570176&h=CvpM%2F%2FaZiJQbDZ%2BbiA53%2B2Lq7HvJm47meP%2FEuSaj5B72EbssU0j7ssJEoVl30dX9ZyasQcCwnZK0vPGPDbEQLQ%3D%3D&crl=c Characterizing Monoclonal Antibodies and Antibody-Drug Conjugates Using 2D-LC-MS. K Sandra , I Vandenheede, M Steenbeke - LC-GC , 2017 - search.ebscohost.comhttps://search.ebscohost.com/login.aspx?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=14716577&AN=121933182&h=kjupPM0spnP7Gi7x6T2ToZBElNE%2BZ%2FyKaWEdnYydRYY4fEdOvMAbmey%2FAnCBoxNBs6xrN%2BB9oQvyTEZAVvrLJA%3D%3D&crl=c Investigation of the correlation between charge and glycosylation of IgG1 variants by liquid chromatography-mass spectrometry JM Yang, J Ai, Y Bao, Z Yuan, Y Qin, YW Xie, D Tao - Analytical , 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003269713005642 Antibody characterization using novel ERLIC-MS/MS-based peptide mapping J Zhen, J Kim, Y Zhou, E Gaidamauskas - MAbs, 2018 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/19420862.2018.1505179 Monoclonal Antibodies and Biosimilars-A Selection of Analytical Tools for Characterization and Comparability Assessment I Vandenheede, P Sandra , K Sandra - LCGC , 2015 - chromatographyonline.comhttps://www.chromatographyonline.com/view/monoclonal-antibodies-and-biosimilars-selection-analytical-tools-characterization-and-comparabilit-0 Monoclonal Antibodies and Biosimilars-A Selection of Analytical Tools for Characterization and Comparability Assessment I Vandenheede, P Sandra , K Sandra, E Dumont - 2016 - chromatographyonline.comhttps://www.chromatographyonline.com/view/monoclonal-antibodies-and-biosimilars-selection-analytical-tools-characterization-and-comparabilit-1 Peptide map of monoclonal antibodies and antibody-drug conjugates using micro-pillar array columns combined with mass spectrometry I Vandenheede, P Sandra , G Desmet, W De Malsche - 2018 - chromatographyonline.comhttps://www.chromatographyonline.com/view/peptide-mapping-monoclonal-antibodies-and-antibody-drug-conjugates-using-micro-pillar-array-columns Peptide Mapping of Monoclonal Antibodies and Antibody-Drug Conjugates Using Micro-Pillar Array Columns Combined with Mass Spectrometry I Vandenheede, P Sandra , G Desmet, W De Malsche - 2018 - chromatographyonline.comhttps://www.chromatographyonline.com/view/peptide-mapping-monoclonal-antibodies-and-antibody-drug-conjugates-using-micro-pillar-array-column-2 Similarity demonstrated between isolated charge variants of MB02, a biosimilar of bevacizumab, and Avastin® following extended physicochemical and functional I Ruppen, ME Beydon, C Solaca­s, D Sacristan - Biologicals, 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1045105621000786 The second life of antibodies EV Navolotskaya - Biochemistry (Moscow), 2014 - Springerhttps://link.springer.com/article/10.1134/S0006297914010015 Detection and identification of a serine to arginine sequence variant in a therapeutic monoclonal antibody D Ren, J Zhang, R Pritchett, H Liu, J Kyauk - of Chromatography B, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1570023211005411 Observation of Heavy-Chain C-Terminal Des-GK Truncation in Recombinant and Human Endogenous IgG4 B Shah, YX Zhu , J Wypych, Z Zhang - Journal of Pharmaceutical Sciences, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022354923001922 Observation of heavy-chain C-terminal amidation in human endogenous IgG B Shah, M Li, J Wypych, MK Joubert, Z Zhang - Journal of Pharmaceutical , 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022354922002568 C-terminal lysine processing of human immunoglobulin G2 heavy chain in vivo B Cai, H Pan, GC Flynn - Biotechnology and bioengineering, 2011 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/bit.22933

Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:

Chemische Eigenschaften

MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:

Gefahrenhinweise

UN-Nummer:
EQ:
Klasse:
H-Sätze:
P-Sätze:
Flugverbot:
Gefahrenhinweis:
Verpackungsgruppe:
LQ:

Technische Anfrage zu: 3D-PP47581 H-SLSLSPGK-OH

Bitte verwenden Sie stattdessen den Warenkorb, um ein Angebot oder eine Bestellung anzufordern

Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.

* Obligatorische felder
Willkommen bei CymitQuimica!Wir verwenden Cookies, um Ihren Besuch zu verbessern. Wir schließen Werbung nicht ein.

Bitte beachten Sie unsere Cookie-Richtlinie  für weitere Details oder passen Sie Ihre Einstellungen unter “Konfigurieren” an.